HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

67.150

+5.0008.05%

Volume:4.13M

Turnover:270.37M

Market Cap:38.38B

PE:-282.14

High:69.000

Open:63.500

Low:60.000

Close:62.150

52wk High:72.400

52wk Low:29.980

Shares:571.62M

HK Float Shares:571.62M

Volume Ratio:1.88

T/O Rate:0.72%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.238

ROE:--

ROA:--

PB:-7.21

PE(LYR):-282.14

PS:91.62

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Insilico Medicine ernennt Halle Zhang zur Vizepräsidentin für klinische Entwicklung in der Onkologie

Insilico Medicine Appoints Halle Zhang, Phd (Med), as Vice President, Clinical Development - Oncology

THOMSON REUTERS

Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien

Insilico Medicine Nominates ISM5059, the Peripheral-Restricted Nlrp3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/03696"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":67.15,"timestamp":1770624509052,"preClose":62.15,"halted":0,"volume":4128708,"delay":0,"changeRate":0.08045052292839915,"floatShares":571622000,"shares":571622000,"eps":-0.238,"marketStatus":"Closed","change":5,"latestTime":"02-09 16:08:29","open":63.5,"high":69,"low":60,"amount":270369700,"amplitude":0.144811,"askPrice":67.3,"askSize":1500,"bidPrice":67.15,"bidSize":7000,"shortable":0,"etf":0,"ttmEps":-0.624,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770687000000},"marketStatusCode":5,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":62.15,"openAndCloseTimeList":[[1770600600000,1770609600000],[1770613200000,1770624000000]],"volumeRatio":1.88141,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":571622000,"roa":"--","roe":"--","lyrEps":-0.238,"volumeRatio":1.88141,"shares":571622000,"dividePrice":0,"high":69,"amplitude":0.144811,"preClose":62.15,"low":60,"week52Low":29.98,"pbRate":"-7.21","psRate":"91.62","week52High":72.4,"institutionHeld":0,"latestPrice":67.15,"committee":0.647059,"eps":-0.238,"divideRate":0,"volume":4128708,"delay":0,"ttmEps":-0.624,"open":63.5,"prevYearClose":37.14,"prevWeekClose":62.15,"prevMonthClose":62.9,"prevQuarterClose":37.14,"fiveDayClose":60.25,"twentyDayClose":54.5,"sixtyDayClose":24.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-02-06","current":-103.445513,"percent":0.214286,"low":-113.684384,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"high":-38.773669,"avg":-86.032197,"sd":19.799582,"marketCap":35423424190},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190}],"updateTime":1770609768876},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609595962","title":"Insilico Medicine ernennt Halle Zhang zur Vizepräsidentin für klinische Entwicklung in der Onkologie","url":"https://stock-news.laohu8.com/highlight/detail?id=2609595962","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609595962?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:00","pubTimestamp":1770382853,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via PR Newswire  on February 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL74yyKb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2609955175","title":"Insilico Medicine Appoints Halle Zhang, Phd (Med), as Vice President, Clinical Development - Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2609955175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609955175?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:00","pubTimestamp":1770382801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA5C2TQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2609308878","title":"Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien","url":"https://stock-news.laohu8.com/highlight/detail?id=2609308878","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609308878?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:01","pubTimestamp":1770296515,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via PR Newswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL2fYx8C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2609230886","title":"Insilico Medicine Nominates ISM5059, the Peripheral-Restricted Nlrp3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2609230886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609230886?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:01","pubTimestamp":1770296514,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nFWN3Z10QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/03696\",params:#limit:6,delay:false,,,undefined,":[]}}